Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
医学
多西紫杉醇
前列腺癌
雄激素剥夺疗法
相伴的
肿瘤科
内科学
癌症
作者
Christopher J. Sweeney,Yu‐Hui Chen,Michael A. Carducci,Glenn Liu,David F. Jarrard,Mario A. Eisenberger,Yu-Ning Wong,Noah M. Hahn,Manish Kohli,Matthew M. Cooney,Robert Dreicer,Nicholas J. Vogelzang,Joel Picus,Daniel H. Shevrin,Maha Hussain,Jorge A. García,Robert S. DiPaola
Androgen-deprivation therapy (ADT) has been the backbone of treatment for metastatic prostate cancer since the 1940s. We assessed whether concomitant treatment with ADT plus docetaxel would result in longer overall survival than that with ADT alone.